Resveratrol and ivacaftor are additive G551D CFTR‐channel potentiators: therapeutic implications for cystic fibrosis sinus disease - Concepedia

Concepedia

Publication | Closed Access

Resveratrol and ivacaftor are additive G551D CFTR‐channel potentiators: therapeutic implications for cystic fibrosis sinus disease

24

Citations

33

References

2018

Year

Do‐Yeon Cho, Shaoyan Zhang, Ahmed Lazrak, Jessica W. Grayson, Jaime Garcia, Daniel Skinner, Dong Jin Lim, Calvin Mackey, Catherine Banks, Sadis Matalon,

International Forum of Allergy & Rhinology

Abstract

Additive improvement in G551D CFTR-mediated Cl<sup>-</sup> secretion suggests that resveratrol could enhance ivacaftor therapy in these patients and improve CF-related rhinosinusitis.

References

	Year	Citations

Page 1